Cargando…

Glucose metabolic reprogramming in autoimmune diseases

Autoimmune diseases are conditions in which the immune system mistakenly targets and damages healthy tissue in the body. In recent decades, the incidence of autoimmune diseases has increased, resulting in a significant disease burden. The current autoimmune therapies focus on targeting inflammation...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jeong, Hoim, Lee, Beomgu, Han, Seung Jin, Sohn, Dong Hyun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2023
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10351453/ https://www.ncbi.nlm.nih.gov/pubmed/37465289 http://dx.doi.org/10.1080/19768354.2023.2234986

Ejemplares similares

Mirodenafil ameliorates skin fibrosis in bleomycin-induced mouse model of systemic sclerosis
por: Roh, Jong Seong, et al.
Publicado: (2021)

FAT10 Induces cancer cell migration by stabilizing phosphorylated ABI3/NESH
por: Um, Hyojin, et al.
Publicado: (2023)

VNN3 is a potential novel biomarker for predicting prognosis in clear cell renal cell carcinoma
por: Ha, Mihyang, et al.
Publicado: (2019)

The Role of Reprogrammed Glucose Metabolism in Cancer
por: Ediriweera, Meran Keshawa, et al.
Publicado: (2023)

The roles of glucose metabolic reprogramming in chemo- and radio-resistance
por: Lin, Jinguan, et al.
Publicado: (2019)

Reprogramming Metabolism of Macrophages as a Target for Kidney Dysfunction Treatment in Autoimmune Diseases
por: Tian, Feng, et al.
Publicado: (2022)

Reprogramming of glucose metabolism in hepatocellular carcinoma: Progress and prospects
por: Shang, Run-Ze, et al.
Publicado: (2016)

Extracellular histones aggravate autoimmune arthritis by lytic cell death
por: Jung, Jaeyong, et al.
Publicado: (2022)

Glucose Metabolic Dysfunction in Neurodegenerative Diseases—New Mechanistic Insights and the Potential of Hypoxia as a Prospective Therapy Targeting Metabolic Reprogramming
por: Han, Rongrong, et al.
Publicado: (2021)

Glucose metabolism reprogramming promotes immune escape of hepatocellular carcinoma cells
por: Zhang, Qiuyue, et al.
Publicado: (2023)

Role of Glucose Metabolic Reprogramming in Breast Cancer Progression and Drug Resistance
por: Lei, Pan, et al.
Publicado: (2023)

Reprogramming of glucose metabolism in virus infected cells
por: Goyal, Priya, et al.
Publicado: (2023)

Autonomous glucose metabolic reprogramming of tumour cells under hypoxia: opportunities for targeted therapy
por: Huang, Mingyao, et al.
Publicado: (2020)

Role of Glucose Metabolism Reprogramming in the Pathogenesis of Cholangiocarcinoma
por: Pant, Kishor, et al.
Publicado: (2020)

Glucose metabolic reprogramming and its therapeutic potential in obesity-associated endometrial cancer
por: Huang, Pengzhu, et al.
Publicado: (2023)

Non-coding RNAs in breast cancer: with a focus on glucose metabolism reprogramming
por: Liang, Junjie, et al.
Publicado: (2023)

Metabolic Reprogramming of Innate Immune Cells as a Possible Source of New Therapeutic Approaches in Autoimmunity
por: Mohammadnezhad, Leila, et al.
Publicado: (2022)

Myeloid IPMK promotes the resolution of serum transfer-induced arthritis in mice
por: Ahn, Hyoungjoon, et al.
Publicado: (2021)

MYCN and Metabolic Reprogramming in Neuroblastoma
por: Bansal, Mohit, et al.
Publicado: (2022)

Glypican-3 Enhances Reprogramming of Glucose Metabolism in Liver Cancer Cells
por: Yao, Gebing, et al.
Publicado: (2019)

The potential role of reprogrammed glucose metabolism: an emerging actionable codependent target in thyroid cancer
por: Duan, Sai-li, et al.
Publicado: (2023)

Role of Metabolic Reprogramming in Epithelial–Mesenchymal Transition (EMT)
por: Kang, Hyunkoo, et al.
Publicado: (2019)

Metabolic reprogramming heterogeneity in chronic kidney disease
por: Miguel, Verónica, et al.
Publicado: (2023)

Cucurbitacin D Reprograms Glucose Metabolic Network in Prostate Cancer
por: Sikander, Mohammed, et al.
Publicado: (2019)

HIF-1-Dependent Reprogramming of Glucose Metabolic Pathway of Cancer Cells and Its Therapeutic Significance
por: Nagao, Ayako, et al.
Publicado: (2019)

Itaconate ameliorates autoimmunity by modulating T cell imbalance via metabolic and epigenetic reprogramming
por: Aso, Kuniyuki, et al.
Publicado: (2023)

Immune cell metabolism and metabolic reprogramming
por: Hu, Chenchen, et al.
Publicado: (2022)

Metabolic reprogramming in cancer: Mechanisms and therapeutics
por: Nong, Shiqi, et al.
Publicado: (2023)

Glucose metabolism and glycosylation link the gut microbiota to autoimmune diseases
por: Wang, Lu, et al.
Publicado: (2022)

Multi-omics analyses of glucose metabolic reprogramming in colorectal cancer
por: Huang, Maosen, et al.
Publicado: (2023)

Lipid metabolic reprogramming in tumor microenvironment: from mechanisms to therapeutics
por: Jin, Hao-Ran, et al.
Publicado: (2023)

Metabolic reprogramming in triple-negative breast cancer
por: Wang, Zhanyu, et al.
Publicado: (2020)

Snail reprograms glucose metabolism by repressing phosphofructokinase PFKP allowing cancer cell survival under metabolic stress
por: Kim, Nam Hee, et al.
Publicado: (2017)

Regulation of autoimmune disease progression by Pik3ip1 through metabolic reprogramming in T cells and therapeutic implications
por: Xie, Wenqiang, et al.
Publicado: (2022)

T-cell metabolism in autoimmune disease
por: Yang, Zhen, et al.
Publicado: (2015)

The cancer metabolic reprogramming and immune response
por: Xia, Longzheng, et al.
Publicado: (2021)

Maladaptive T-Cell Metabolic Fitness in Autoimmune Diseases
por: Antony, Irene Rose, et al.
Publicado: (2023)

Metabolic reprogramming in macrophage responses
por: Liu, Yang, et al.
Publicado: (2021)

Metabolic Reprogramming in COVID-19
por: Shen, Tao, et al.
Publicado: (2021)

Metabolic Reprogramming of Liver Fibrosis
por: Delgado, M. Eugenia, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_321t4nv8s45jb92fhurdrprve7